Literature DB >> 18776818

Acyclovir-resistant chronic verrucous vaccine strain varicella in a patient with neuroblastoma.

Coleman J Bryan1, Mark N Prichard, Shannon Daily, Geraldine Jefferson, Caroll Hartline, Kevin A Cassady, Lee Hilliard, Masako Shimamura.   

Abstract

A 21-month-old girl with neuroblastoma developed chronic verrucous Oka strain varicella-zoster infection during chemotherapy. Virus isolated from the patient demonstrated high-level acyclovir resistance, and its thymidine kinase had no in vitro enzymatic activity. After foscarnet therapy, she underwent stem cell transplantation without varicella reactivation. This is only the second reported case of resistant varicella zoster virus caused by Oka strain virus.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18776818     DOI： 10.1097/INF.0b013e318175d85c

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  9 in total

1.  A Toddler With Rash, Encephalopathy, and Hemolytic Anemia.

Authors:  Christiana Smith; Cullen Dutmer; D Scott Schmid; Megan K Dishop; William J Bellini; Erwin W Gelfand; Edwin J Asturias
Journal:  J Pediatric Infect Dis Soc       Date:  2015-05-28       Impact factor: 3.164

2.  Differences in the Likelihood of Acyclovir Resistance-Associated Mutations in the Thymidine Kinase Genes of Herpes Simplex Virus 1 and Varicella-Zoster Virus.

Authors:  Hikaru Fujii; Shizuko Harada; Tomoki Yoshikawa; Souichi Yamada; Natsumi Omura; Miho Shibamura; Takuya Inagaki; Hirofumi Kato; Shuetsu Fukushi; Masayuki Saijo
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

3.  Vaccine Oka Varicella Meningitis in Two Adolescents.

Authors:  Whitney E Harrington; Sayonara Mató; Lauri Burroughs; Paul A Carpenter; Anne Gershon; D Scott Schmid; Janet A Englund
Journal:  Pediatrics       Date:  2019-12       Impact factor: 7.124

Review 4.  Antiviral drug resistance: mechanisms and clinical implications.

Authors:  Lynne Strasfeld; Sunwen Chou
Journal:  Infect Dis Clin North Am       Date:  2010-06       Impact factor: 5.982

5.  The varicella-zoster virus portal protein is essential for cleavage and packaging of viral DNA.

Authors:  Melissa A Visalli; Brittany L House; Anca Selariu; Hua Zhu; Robert J Visalli
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

Review 6.  Pathogenesis and current approaches to control of varicella-zoster virus infections.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

7.  Fatal varicella due to the vaccine-strain varicella-zoster virus.

Authors:  Jessica Leung; Subhadra Siegel; James F Jones; Cynthia Schulte; Debra Blog; D Scott Schmid; Stephanie R Bialek; Mona Marin
Journal:  Hum Vaccin Immunother       Date:  2013-08-27       Impact factor: 3.452

8.  Deficit of Anterior Pituitary Function and Variable Immune Deficiency Syndrome: A Novel Mutation.

Authors:  Pavadee Poowuttikul; Eric McGrath; Deepak Kamat
Journal:  Glob Pediatr Health       Date:  2017-01-27

Review 9.  Advances and Perspectives in the Management of Varicella-Zoster Virus Infections.

Authors:  Graciela Andrei; Robert Snoeck
Journal:  Molecules       Date:  2021-02-20       Impact factor: 4.411
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.